Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (171-180 of 280) with videos related to

Pageof 28
Sort By:
Cancer Research|January 2, 2009
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factorsThomas Vaissière, Rayjean J Hung, David Zaridze, et al.
Cancer Cell|May 5, 2009
PRIMA-1 reactivates mutant p53 by covalent binding to the core domainJeremy M R Lambert, Petr Gorzov, Dimitry B Veprintsev, et al.
Nature Communications|September 29, 2025
TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroupNicholas W Fischer, Noel Ong, Brianne Laverty, et al.
Cancer Letters|August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteinsOivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicityGregory D Kirk, Paul C Turner, Yunyun Gong, et al.
Environmental Health Perspectives|December 6, 2008
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West AfricaMark H Kuniholm, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Biopreservation and Biobanking|May 20, 2014
Pathology as the cornerstone of human tissue banking: European consensus expert group reportPierre Hainaut, Elodie Caboux, Generoso Bevilacqua, et al.
Clinical Lung Cancer|October 31, 2013
Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomasAlexis B Cortot, Mohamad Younes, Ghislaine Martel-Planche, et al.
Carcinogenesis|October 2, 2014
Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcriptsLaury Perriaud, Virginie Marcel, Charlotte Sagne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancerSimonetta Viviani, Patrizia Carrieri, Ebrima Bah, et al.
Pageof 28

Showing results (171-180 of 280) with videos related to

Sort By:
Pageof 28
Cancer Research|January 2, 2009
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factorsThomas Vaissière, Rayjean J Hung, David Zaridze, et al.
Cancer Cell|May 5, 2009
PRIMA-1 reactivates mutant p53 by covalent binding to the core domainJeremy M R Lambert, Petr Gorzov, Dimitry B Veprintsev, et al.
Nature Communications|September 29, 2025
TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroupNicholas W Fischer, Noel Ong, Brianne Laverty, et al.
Cancer Letters|August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteinsOivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicityGregory D Kirk, Paul C Turner, Yunyun Gong, et al.
Environmental Health Perspectives|December 6, 2008
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West AfricaMark H Kuniholm, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Biopreservation and Biobanking|May 20, 2014
Pathology as the cornerstone of human tissue banking: European consensus expert group reportPierre Hainaut, Elodie Caboux, Generoso Bevilacqua, et al.
Clinical Lung Cancer|October 31, 2013
Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomasAlexis B Cortot, Mohamad Younes, Ghislaine Martel-Planche, et al.
Carcinogenesis|October 2, 2014
Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcriptsLaury Perriaud, Virginie Marcel, Charlotte Sagne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancerSimonetta Viviani, Patrizia Carrieri, Ebrima Bah, et al.
Pageof 28